WEB DESK
Brazilian health regulator Anvisa has said that Chinese health authorities had not been transparent in approving its COVID-19 vaccine ‘CoronaVac’ for emergency use.
CoronaVac, produced by the Chinese private laboratory Sinovac is currently undergoing phase 3 clinical trials in Sao Paulo.
The health regulator in a statement noted that while the vaccine has had an emergency use authorization in China since June, the country’s authorities have not been transparent about the criteria used for granting this authorization.
Brazilian President Jair Bolsonaro has repeatedly cast doubt on the CoronaVac vaccine.